Evidence map›Paper›PMID 25212602›Full record

ReviewNature reviews. Drug discovery2014

Caloric restriction mimetics: towards a molecular definition.

Frank Madeo, Federico Pietrocola, Tobias Eisenberg, Guido Kroemer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Drug discovery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 2 syntheses or guidelines pooled it, 234 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. The geroprotective potential of chalcones.Nature communications · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Frank MadeoInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Federico PietrocolaEquipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, F-75006 Paris, France and the Université Paris Descartes, Sorbonne Paris Cité, F-75006 Paris, France.
Tobias EisenbergInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Guido KroemerEquipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, F-75006 Paris, France; the Université Paris Descartes, Sorbonne Paris Cité, F-75006 Paris, France; the Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Labex Immuno-Oncology, F-75015 Paris, France; and the Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, F-94805 Villejuif, France.
University of Graz · ATAssistance Publique – Hôpitaux de Paris · FRCentre de Recherche des Cordeliers · FR

Funding

Austrian Science Fund FWF I 1000Austrian Science Fund FWF P 23490Austrian Science Fund FWF P 24381
6 · The paper itself

Abstract

Caloric restriction, be it constant or intermittent, is reputed to have health-promoting and lifespan-extending effects. Caloric restriction mimetics (CRMs) are compounds that mimic the biochemical and functional effects of caloric restriction. In this Opinion article, we propose a unifying definition of CRMs as compounds that stimulate autophagy by favouring the deacetylation of cellular proteins. This deacetylation process can be achieved by three classes of compounds that deplete acetyl coenzyme A (AcCoA; the sole donor of acetyl groups), that inhibit acetyl transferases (a group of enzymes that acetylate lysine residues in an array of proteins) or that stimulate the activity of deacetylases and hence reverse the action of acetyl transferases. A unifying definition of CRMs will be important for the continued development of this class of therapeutic agents.

Indexed as

Drug DesignAcetylationAcetyl Coenzyme AAcetyltransferasesAnimalsAutophagyCaloric RestrictionHumansAcetyl Coenzyme AAcetyltransferases

Identifiers

PMID25212602
OpenAlexW1991853144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.